Dr. William L. Surbeck, MD

Dr. Surbeck practices at Union Pines Surgery Center in Tulsa, Oklahoma.

Dr. Surbeck's NPI, 1154382711, was assigned on March 31, 2006. Dr. Surbeck graduated from University of Oklahoma College of Medicine in 1988. Dr. Surbeck holds Oklahoma license 16971.

Dr. Surbeck's primary practice is Union Pines Surgery Center, at 4808 South 109th East Avenue, Tulsa, OK 74146. The practice phone is (918) 742-2502. Dr. Surbeck also practices at Union Pines Surgery Center,LLC, 4800 S 109th E Ave, Tulsa, OK 74146.

Dr. Surbeck's primary practice is Union Pines Surgery Center in Tulsa, Oklahoma. Dr. Surbeck is also affiliated with Saint Francis Hospital. The medical group on file is Tulsa Bone & Joint Associates. Dmand AI also links Dr. Surbeck to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Surbeck practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Surbeck's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Surbeck is board certified in rheumatology by the American Board of Internal Medicine. Dr. Surbeck is licensed in Oklahoma.

CMS data shows 200,413 Medicare services from Dr. Surbeck across 20 procedure codes in 2024, for 518 Medicare patients. Medicare paid $1,890,465 for them. Every service was in an office.

CMS counts 518 Medicare patients who saw Dr. Surbeck in 2024. The largest group is 65 to 74, with 261 patients. 75% of them have arthritis, and 74% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Surbeck's median patient age at 67, with 79% women.

In 2024, Dr. Surbeck wrote 5,624 Medicare Part D claims for 626 patients. 85% of them were for generic drugs. CMS names the drug for 5,418 of them, across 50 drugs with 11 or more claims each, at $5,053,689 in total drug cost. In 2023, CMS named 5,742 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Surbeck for performance year 2024, reported as part of a group. Dr. Surbeck accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Surbeck to 1 clinical trial. Conditions studied include Arthritis, Rheumatoid and Rheumatic Diseases. Open Payments lists research payments to Dr. Surbeck that name 1 trial.

CMS Open Payments shows 1,284 general payments to Dr. Surbeck from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Janssen Pharmaceuticals, Inc paid the most, $5,045. It also lists 2 research payments totaling $1,752 from 2018 to 2019, naming 1 clinical trial.

Dr. Surbeck graduated from University of Oklahoma College of Medicine in 1988.